cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Bluebird Bio Inc
36 own
40 watching
Current Price
$8.51
$0.05
(0.59%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
117.83M
52-Week High
52-Week High
38.40000
52-Week Low
52-Week Low
5.80000
Average Volume
Average Volume
0.12M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization117.83M
icon52-Week High38.40000
icon52-Week Low5.80000
iconAverage Volume0.12M
iconDividend Yield--
iconP/E Ratio--
What does the Bluebird Bio Inc do?
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. It markets three gene therapies: ZYNTEGLO (betibeglogene autotemcel, also known as beti-cel), SKYSONA (elivaldogene autotemcel, also known as eli-cel), and LYFGENIA (lovotibeglogene autotemcel, also known as lovo-cel). ZYNTEGLO is the first gene therapy for the treatment of adult and pediatric patients with ß-thalassemia who require regular red blood cell transfusions. SKYSONA is used to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). LYFGENIA was approved by the FDA for the treatment of patients 12 years of age or older with sickle cell disease (SCD) and a history of vaso-occlusive events (VOEs). It is focused on pursuing curative gene therapies.
Read More
How much money does Bluebird Bio Inc make?
News & Events about Bluebird Bio Inc.
PR Newswire
1 year ago
Thinking about buying stock in bluebird bio, Uniqure, Terawulf, Metaworks Platforms, or Nikola Corp? Thinking about buying stock in bluebird bio, Uniqure, Terawulf, Metaworks Platforms, or Nikola Corp? PR Newswire NEW YORK, June 21, 2023 NEW YORK, June 21, 2023 /PRNewswire/ -- InvestorsObserver...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE PR Newswire NEW YORK, May 2, 2023 NEW YORK, May 2, 2023 /PRNewswire...
Globe Newswire
1 year ago
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. (bluebird or the Company) (NASDAQ: BLUE). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
Globe Newswire
1 year ago
NEW YORK, April 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. (bluebird or the Company) (NASDAQ: BLUE). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
Ticker Report
1 year ago
bluebird bio (NASDAQ:BLUE Get Rating) and Harpoon Therapeutics (NASDAQ:HARP Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst ...
Frequently Asked Questions
Frequently Asked Questions
What is Bluebird Bio Inc share price today?
plus_minus_icon
Can Indians buy Bluebird Bio Inc shares?
plus_minus_icon
How can I buy Bluebird Bio Inc shares from India?
plus_minus_icon
Can Fractional shares of Bluebird Bio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Bluebird Bio Inc stocks?
plus_minus_icon
What is today’s traded volume of Bluebird Bio Inc?
plus_minus_icon
What is today’s market capitalisation of Bluebird Bio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Bluebird Bio Inc?
plus_minus_icon
What percentage is Bluebird Bio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Bluebird Bio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$8.51
$0.05
(0.59%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Inari Medical Inc
Inari Medical Inc
$79.31
$0.03 (0.03 %)
AxoGen, Inc.
AxoGen, Inc.
$18.25
$0.20 (1.11 %)
CEL-SCI Corp
CEL-SCI Corp
$0.41
$-0.02 (-5.77 %)
Fate Therapeutics Inc
Fate Therapeutics Inc
$1.30
$-0.17 (-11.79 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Inari Medical Inc
Inari Medical Inc
$79.31
$0.03 (0.03 %)
AxoGen, Inc.
AxoGen, Inc.
$18.25
$0.20 (1.11 %)
CEL-SCI Corp
CEL-SCI Corp
$0.41
$-0.02 (-5.77 %)
Fate Therapeutics Inc
Fate Therapeutics Inc
$1.30
$-0.17 (-11.79 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00